Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.430
-1.500 (-51.19%)
Jun 29, 2026, 3:07 PM EDT - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.48 million as of June 29, 2026. Its market cap has decreased by -44.05% in one year.
Market Cap
1.48M
Enterprise Value
-2.27M
1-Year Change
-44.05%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.42M to $1.48M, a decrease of -97.81%. That is a compound annual growth rate of -56.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 1.48M | 22.25% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.09% |
| Dec 29, 2023 | 1.51M | -80.24% |
| Dec 30, 2022 | 7.65M | -84.67% |
| Dec 31, 2021 | 49.89M | -26.00% |
| Nov 10, 2021 | 67.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enVVeno Medical | 7.24M |
| Beyond Air | 6.53M |
| Vivos Therapeutics | 6.22M |
| Tenon Medical | 5.93M |
| Biomerica | 5.41M |
| Intelligent Bio Solutions | 5.38M |
| INVO Fertility | 4.38M |
| ENvue Medical | 3.51M |